Expanded Core-Shell Column Line to Include a 5 µm Particle Size for Small-Scale Purifications

Environmental laboratory

Expanded Core-Shell Column Line to Include a 5 µm Particle Size for Small-Scale Purifications

22 Sep, 2014

Published over 11 years ago. See the latest and most current information on Environmental laboratory.

Phenomenex Inc. (USA) announces the addition of a 5 µm particle size to its family of Aeris PEPTIDE core-shell columns, enabling higher efficiencies and higher loading capability for small-scale peptide purification in 10 mm ID semi-prep columns and 21.2 mm ID Axia-packed prep columns. Aeris PEPTIDE is fully scalable over four particle sizes – 1.7 µm, 2.6 µm, 3.6 µm, and 5 µm – enabling easy method transfer from analytical HPLC and UHPLC to preparative applications. Aeris PEPTIDE is ideal for biomolecule separations in pharmaceutical and life science applications.

The Phenomenex Axia preparative format delivers longer column lifetime, higher efficiencies, improved performance and high reproducibility, compared to conventionally packed columns for lab-scale preparative chromatography.

“We are continually expanding our core-shell products to provide our customers with seamless scalability providing the same selectivity and retention over the range of particle sizes,” comments Michael Klein, brand manager for Phenomenex. “Aeris is the leading choice for the separation of biomolecules and we now offer the largest number of formats of any core-shell product engineered for biomolecules on the market.” 

Latest News

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
SLAS2027 Innovation Ave Applications Open for Life Sciences Start-Ups
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Smart fuel lubricity testers for modern labs
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow